Showing 2 posts of 2 posts found.
MSD, known as Merck in the US and Canada, has announced that it has finally decided to discontinue the development …
Product value to pathway impact: What the CVD Modern Service Framework means for pharma
Functional lung imaging offers new possibilities for respiratory care
Five Facts about cardiovascular disease
Data integrity: the keystone for AI adoption, patient safety and organisational reputation
Artificial hearts: a century of innovation